Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities

Phytomedicine

Volumn 11, Issue 5, 2004, Pages 392-403

  Seidlova Wuttke D ^a   Hesse, O ^a   Jarry, H ^a   Rimoldi, G ^a   Thelen, P ^a   Christoffel, V ^b   Wuttke, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Bionorica AG   (Germany)

Author keywords

Belamcanda chinensis; Estrogen receptor modulation; Isoflavones; Tectorigenin

Indexed keywords

BELAMCANDA CHINENSIS EXTRACT; BIOLOGICAL MARKER; BNO 1420; CYCLINE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOFLAVONE; PLANT EXTRACT; RECOMBINANT ESTROGEN RECEPTOR ALPHA; RECOMBINANT ESTROGEN RECEPTOR BETA; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TECTORIGENIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BELAMCANDA CHINENSIS; BONE; BONE DENSITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; ESTROGEN ACTIVITY; FEMALE; GENE EXPRESSION; HOT FLUSH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IRIDACEAE; LUTEINIZING HORMONE RELEASE; MAMMARY GLAND; MDA MB231 GENE; MODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; RAT; RECEPTOR BINDING; REPORTER GENE; RHIZOME; TIBIA; TRANSACTIVATION; UTERUS WEIGHT;

BELAMCANDA CHINENSIS; IRIDACEAE;

EID: 3242764487     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.01.003     Document Type: Article

References (42)

1. Adesanya, O.O., Zhou, J., Samathanam, C., Powell-Braxton, L., Bondy, C.A., 1999. Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle. Proc. Natl. Acad. Sci. USA 96, 3287-3291.
2. Allred, C.D., Allred, K.F., Ju, Y.H., Virant, S.M., Helferich, W.G., 2001. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer. Res. 61, 5045-5050.
3. Beenken, S.W., Bland, K.I., 2002. Biomarkers for breast cancer. Minerva. Chir. 57, 437-448.
4. Beral, V., Million Women Study Collaborators, 2003. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419-427.
5. Burger, H., 2003. Hormone replacement therapy in the post-Women's Health Initiative era. Climacteric 6, 11-36.
6. Burke, G.L., Legault, C., Anthony, M., Bland, D.R., Morgan, T.M., Naughton, M.J., Leggett, K., Washburn, S.A., Bitolins, M.Z., 2003. Soy protein and isoflavone effect on vasomotor symptoms in peri-and postmenopausal women: the soy estrogen alternative study. Menopause 10, 147-153.
7. Davis, S.R., 2003. Menopause: new therapies. MJA 178, 634-637.
8. Diel, P., Smolnikar, K., Schulz, T., Laudenbach-Leschowski, U., Michna, H., Vollmer, G., 2001. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum. Reprod. 16, 997-1006.
9. Gambone, J., Meldrun, D.R., Laufer, L., Chang, R.J., Lu, J.K., Judd, H.L., 1984. Further delineation of hypothlamaic dysfunction responsible for menopausal hot flashes. J. Clinc. Endocrinol. Metab. 59, 1097-1102.
10. Heid, C.A., Stevens, J., Livak, K.J., Williams, P.M., 1996. Real time quantitative PCR. Genome Res. 6, 986-994.
11. Helterbrand, J.D., Higgs Jr., R.E., Iversen, P.W., Tysarczyk-Niemeyer, G., Sato, M., 1997. Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats. Bone 21, 401-409.
12. Jarry, H., Harnischfeger, G., Düker, E., 1985. Studies on the endocrine effects of the contents of Cimicifuga racemosa: 2. In vitro binding of compounds to estrogen receptors. Planta. Med. 51, 316-319.
13. Jarry, H., Metten, M., Spengler, B., Chrisoffel, V., Wuttke, W., 2003. In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas 44 (Suppl. 1), 31-38.
14. Ju, Y.H., Allred, C.D., Alred, K.F., Karko, K.L., Doerge, D.R., Helferich, W.G., 2001. Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr. 131, 2957-2962.
15. Kim, Y.P., Yamada, M., Lim, S.S., Lee, S.H., Ryu, N., Shin, K.H., Ohuchi, K., 1999. Inhibition by tectorigenin and tectoridin of prostaglandin E2 production and caclooxygenase-2 induction in rats peritoneal macrophages. Biochim. Biophys. Acta. 1438, 399-407.
16. Kuiper, G.G., Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustafsson, J.A., 1996. Cloning of a novel receptor expressed in at prostate and ovary. Proc. Natl. Acad. Sci. 93, 5925-5930.
17. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., Gustafsson, J.A., 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870.
18. Lee, K.T., Sohn, I.C., Kim, Y.K., Choi, J.H., Choi, J.W., Park, H.J., Itoh, Y., Miyamoto, K.I., 2001. Tectorigenin, an isoflavone of Pueraria thunbergiana BENTH, induces differentiation and apoptosis in human promyelocytic leukaemia HL-60 cells. Biol. Pharm. Bull. 24, 1117-1121.
19. Liu, H., Hu, X., Ge, J., 1997. Separation and identification of chemical compositions from cultivated Belamcanda chinensis. Zhong. Yao. Cai. 20, 299-301.
20. Maggiolini, M., Bonofiglio, D., Marsico, S., Panno, M.L., Cenni, B., Picard, D., Ando, S., 2001. Estrogen receptor α mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 60, 595-602.
21. Meyer, T., Koop, R., von Angerer, E., Schonenberger, H., Holler, E., 1994. A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J. Cancer. Res. Clin. Oncol. 120, 359-364.
22. Million Women Study Collaborators, 2003. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG 109, 1319-1330.
23. Misumi, Y., Sohda, M., Ikehara, Y., 1990. Nucleotide and deduced amino acid sequence of rat complement C3. Nucl. Acids Res. 18, 2178.
24. Morito, K., Aomori, T., Hirose, T., Kinjo, J., Hasegawa, J., Ogawa, S., Inoue, S., Muramatsu, M., Masamune, Y., 2002. Interaction of phytoestrogens with estrogen receptors α and β. Biol. Pharm. Bull. 25, 48-52.
25. Nenninger, A., Wagner, H., 2004. Chemical composition of Belamcanda chinensis. Phytomedicine, in press.
26. Oh, K.B., Kang, H., Matsuoka, H., 2001. Detection of antifungal activity in Belamcanda chinensis by a single-cell bioassay method and isolation of its active compound, tectorigenin. Biosci. Biotechnol. Biochem. 65, 939-942.
27. Ott, M.O., Sperling, L., Herbomel, P., Yaniv, M., Weiss, M.C., 1984. Tissue-specific expression is conferred by a sequence from the 5′ end of the rat albumin gene. EMBO J. 3, 2505-2510.
28. Palmieri, C., Cheng, G.J., Saji, S., Zelada-Hedman, M., Ẅrri, A., Weihua, Z., Van Noorden, S., Wahlstrom, T., Coombes, R.C., Wartner, M., Gustafsson, J.A., 2002. Estrogen receptor beta in breast cancer. Endocrine-Related Cancer 9, 1-13.
29. Park, K.Y., Jung, G.O., Choi, J., Lee, K.T., Park, H.J., 2002. Potent antimutagenic and their anti-lipid peroxidative effect of kaikasaponin III and tectorigenin from the flower of Pueraria thunbergiana. Arch. Pharm. Res. 25, 320-324.
30. Park-Sarge, O.K., Mayo, K.E., 1994. Regulation of the progesterone receptor gene by gonadotropins and cyclic adenosin 3′,5′- monophosphate in rat granulosa cells. Endocrinology 134, 709-718.
31. Rosenfeld, C.S., Roberts, R.M., Lubahn, D.B., 2001. Estrogen receptor- and aromatase-deficient mice provide insight into the roles of estrogen within the ovary and uterus. Mol. Reprod. Dev. 59, 336-346.
32. Rosenquist, C., Fledelius, C., Christgau, S., Pedersen, B.J., Bonde, M., Qvist, P., Christiansen, C., 1998. Serum CrossLaps one step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin. Chem. 44, 2281-2289.
33. Schoenfeld, J.R., Vasser, M., Jhurani, P., Ng, P., Hunter, J.J., Ross, J., Chien, K.R., Lowe, D.G., 1998. Distinct molecular phenotypes in murine cardiac muscle development, growth and hypertrophy. J. Mol. Cell Cardiol. 30, 2269-2280.
34. Seidlová-Wuttke, D., Jarry, H., Becker, T., Christoffel, V., Wuttke, W., 2003a. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 44 (Suppl. 1), S39-S50.
35. Seidlová-Wuttke, D., Hesse, O., Jarry, H., Christoffel, V., Spengler, B., Becker, T., Wuttke, W., 2003b. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17β. Eur. J. Endocrinol. 149, 351-362.
36. Shin, K.H., Kim, Y.P., Lim, S.S., Lee, S., Ryu, N., Yamada, M., Ohuchi, K., 1999. Inhibition of prostaglandin E2 production by the isoflavones tectorigenin and tectoridin isolated from the rhizomes of Belamcanda chinensis. Planta. Med. 65, 776-777.
37. Tataryn, I.V., Meldrum, D.R., Lu, K.H., Frumar, A.M., Judd, H.L., 1979. LH, FSH and skin temperature during the menopausal hot flash. J. Clin. Endocrinol. Metab. 49, 152-154.
38. Tice, J.A., Ettinger, B., Ensrud, K., Wallae, R., Blackwell, T., Cummings, S.R., 2003. Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA 290, 207-214.
39. Verhaeghe, J., 2003. Turbulent times for hormone replacement therapy: is there a way out? Gynecol. Obstet. Invest. 56, 43-50.
40. Wiesen, J.F., Young, P., Werb, Z., Cunha, G.R., 1999. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126, 335-344.
41. Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
42. Young, M.F., 2003. Bone matrix proteins: their function, regulation, and relationship to osteoporosis. Osteoporos. Int. 14, S35-S42.